Dr. Glynn Wilson - 27 Mar 2026 Form 4 Insider Report for Caring Brands, Inc. (CABR)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: CABR
Reported as of: 27 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Mar 2026, 18:56:31 UTC
Prior SEC filing: 15 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Dr. Glynn Wilson

Key filing fact

Dr. Glynn Wilson filed Form 4 for Caring Brands, Inc. (CABR) on 27 Mar 2026.

Key facts

This page summarizes Dr. Glynn Wilson's Form 4 filing for Caring Brands, Inc. (CABR).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 Mar 2026, 18:56.

Change

Previous filing in this sequence was filed on 15 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001405625 Primary reporting owner

WILSON GLYNN

Relationship: Chief Executive Officer, Director
Address: C/O CARING BRANDS, INC.,, 130 S INDIAN, SUITE 100, FORT PIERCE
Signature: /s/ Dr. Glynn Wilson
Signature date: 27 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CABR transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -1,500,000
Change %: -69%
Price: $0.5000^*
Shares after: 672,592
Date: 27 Mar 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents redemption of 1,500,000 shares of common stock of the Issuer at approximately $0.50 per share pursuant to that certain Share Redemption Agreement signed by the Reporting Person and the Issuer on March 19, 2026.

Footnote F2

The number of shares of common stock beneficially owned following the reported transaction includes Dr. Wilson's ownership of (i) 126,720 restricted stock units of common stock of the Issuer of which zero have vested, (ii) 45,872 restricted stock units of common stock of the Issuer of which zero have vested, and (iii) 500,000 shares of common stock.